Norlase Company
Norlase is an emerging global ophthalmic medical device company developing next-generation laser solutions for the treatment of retina and glaucoma disease. Norlase offers innovative ophthalmic laser solutions, including ECHO and LEAF. ECHO, recognized as the world's first truly portable pattern laser, is battery-powered and equipped with a wireless user interface featuring voice control capabilities. Its design eliminates the need for fiber tethers, enhancing both portability and treatment flexibility. Meanwhile, LEAF is an ultra-compact green laser photocoagulator that attaches directly to existing slit lamps, streamlining laser treatments by removing the need for external fibers or additional equipment.
Funding Status:
Private
Employee Number:
101-250
Last Funding Date:
2025-02-27
Headquarters:
Ballerup,Hovedstaden,Denmark,Europe
Founded Date:
2014-01-01
Total Funding:
45245479
Industry:
Thermometry
Super Industry:
Quantum Sensing
Funding Stage:
Early Stage Venture
Funding Total Value:
45245479
Last Funding Total Usd:
20903671
Last Funding Total Currency:
DKK
Last Funding Total Value:
150000000
Founders:
David Hardwick,Jes Broeng,Oliver Hvidt,Peter Andersen,Peter Skovgaard
Phone Number:
+45 9397 7472